| ![[ICO]](/icons/blank.gif) | Name | Last modified | Size | Description | 
|---|
| 
 | 
|---|
| ![[DIR]](/icons/back.gif) | Parent Directory |  | - |  | 
| ![[   ]](/icons/layout.gif) | ANX FS September 30 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 379K |  | 
| ![[   ]](/icons/layout.gif) | 2017 Year End MD&A.pdf | 22-Feb-2023 10:38 | 1.2M |  | 
| ![[   ]](/icons/layout.gif) | ANX FS March 31, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 320K |  | 
| ![[   ]](/icons/layout.gif) | FY2015 Q1 MD&A.pdf | 22-Feb-2023 10:38 | 144K |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A September 30, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 1.0M |  | 
| ![[   ]](/icons/layout.gif) | Q2 F16 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 112K |  | 
| ![[   ]](/icons/layout.gif) | Q2 F14 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 1.1M |  | 
| ![[   ]](/icons/layout.gif) | FY2015 Audited Annual Financial Statements.pdf | 22-Feb-2023 10:38 | 203K |  | 
| ![[   ]](/icons/unknown.gif) | ANX FS June 30, 2018 - FINAL.PDF | 22-Feb-2023 10:38 | 487K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS December 31, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 737K |  | 
| ![[   ]](/icons/layout.gif) | FY2015 Year End MD&A.pdf | 22-Feb-2023 10:38 | 179K |  | 
| ![[   ]](/icons/layout.gif) | FY2016 Q2 MD&A.pdf | 22-Feb-2023 10:38 | 181K |  | 
| ![[   ]](/icons/layout.gif) | FY2016 Audited Annual Financial Statements.pdf | 22-Feb-2023 10:38 | 622K |  | 
| ![[   ]](/icons/layout.gif) | Q1 F14 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 1.5M |  | 
| ![[   ]](/icons/unknown.gif) | ANX MDA June 30, 2018 - FINAL.PDF | 22-Feb-2023 10:38 | 1.1M |  | 
| ![[   ]](/icons/layout.gif) | Q3 F15 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 109K |  | 
| ![[   ]](/icons/layout.gif) | 2017 Audited Annual Financial Statements.pdf | 22-Feb-2023 10:38 | 717K |  | 
| ![[   ]](/icons/layout.gif) | FY2016 Q3 MD&A.pdf | 22-Feb-2023 10:38 | 1.7M |  | 
| ![[   ]](/icons/layout.gif) | FY2016 Year End MD&A.pdf | 22-Feb-2023 10:38 | 1.8M |  | 
| ![[   ]](/icons/layout.gif) | 2018 Q1 MD&A.pdf | 22-Feb-2023 10:38 | 708K |  | 
| ![[   ]](/icons/layout.gif) | Q2 F17 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 1.1M |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A June 30, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 1.3M |  | 
| ![[   ]](/icons/layout.gif) | Q1 F16 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 109K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA March 31, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 604K |  | 
| ![[   ]](/icons/layout.gif) | Q3 F14 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 111K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS June 30, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 336K |  | 
| ![[   ]](/icons/unknown.gif) | ANX FS March 31, 2018 - FINAL.PDF | 22-Feb-2023 10:38 | 472K |  | 
| ![[   ]](/icons/layout.gif) | FY2014 Audited Annual Financial Statements.pdf | 22-Feb-2023 10:38 | 243K |  | 
| ![[   ]](/icons/layout.gif) | FY2015 Q3 MD&A.pdf | 22-Feb-2023 10:38 | 175K |  | 
| ![[   ]](/icons/layout.gif) | FY2017 Year End MD&A.pdf | 22-Feb-2023 10:38 | 1.3M |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A YE 2018 - FINAL.pdf | 22-Feb-2023 10:38 | 679K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS September 30, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 348K |  | 
| ![[   ]](/icons/layout.gif) | FY2017 Q1 MD&A.pdf | 22-Feb-2023 10:38 | 1.5M |  | 
| ![[   ]](/icons/layout.gif) | ANX FS YE 2018 - FINAL.pdf | 22-Feb-2023 10:38 | 714K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS March 31, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 339K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS December 31, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 670K |  | 
| ![[   ]](/icons/layout.gif) | FY2017 Audited Annual Financial Statements.pdf | 22-Feb-2023 10:38 | 768K |  | 
| ![[   ]](/icons/layout.gif) | Q2 F15 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 109K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS December 31, 2021 FINAL (with Audit Report).pdf | 22-Feb-2023 10:38 | 507K |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A June 30, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 1.0M |  | 
| ![[   ]](/icons/layout.gif) | Q1 F15 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 110K |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A Q3 2018 - FINAL.pdf | 22-Feb-2023 10:38 | 724K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS Q3 2018 - FINAL.pdf | 22-Feb-2023 10:38 | 348K |  | 
| ![[   ]](/icons/layout.gif) | FY2014 Q3 MD&A.pdf | 22-Feb-2023 10:38 | 160K |  | 
| ![[   ]](/icons/unknown.gif) | ANX MDA March 31, 2018 - FINAL.PDF | 22-Feb-2023 10:38 | 1.1M |  | 
| ![[   ]](/icons/layout.gif) | ANX FS September 30, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 348K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS March 31, 2022 Final.pdf | 22-Feb-2023 10:38 | 314K |  | 
| ![[   ]](/icons/layout.gif) | FY2016 Q1 MD&A.pdf | 22-Feb-2023 10:38 | 172K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA December 31, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 1.3M |  | 
| ![[   ]](/icons/layout.gif) | FY2017 Q3 MD&A.pdf | 22-Feb-2023 10:38 | 2.1M |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A Sept 30, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 1.3M |  | 
| ![[   ]](/icons/layout.gif) | FY2014 Year End MD&A.pdf | 22-Feb-2023 10:38 | 165K |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A March 31, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 1.2M |  | 
| ![[   ]](/icons/layout.gif) | FY2014 Q1 MD&A.pdf | 22-Feb-2023 10:38 | 307K |  | 
| ![[   ]](/icons/layout.gif) | FY2017 Q2 MD&A.pdf | 22-Feb-2023 10:38 | 2.0M |  | 
| ![[   ]](/icons/layout.gif) | ANX FS June 30, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 364K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA June 30, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 611K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA December 31, 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 1.2M |  | 
| ![[   ]](/icons/layout.gif) | ANX MD&A March 31, 2020 FINAL.pdf | 22-Feb-2023 10:38 | 1.2M |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA March 31, 2022 Final.pdf | 22-Feb-2023 10:38 | 966K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS March 31, 2020 FINAL.pdf | 22-Feb-2023 10:38 | 330K |  | 
| ![[   ]](/icons/layout.gif) | Q3 F16 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 1.1M |  | 
| ![[   ]](/icons/layout.gif) | FY2014 Q2 MD&A.pdf | 22-Feb-2023 10:38 | 365K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA September 30 2019 - FINAL.pdf | 22-Feb-2023 10:38 | 732K |  | 
| ![[   ]](/icons/layout.gif) | Q1 FY18 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 598K |  | 
| ![[   ]](/icons/layout.gif) | ANX FS June 30, 2020 - FINAL.pdf | 22-Feb-2023 10:38 | 349K |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA December 31, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 1.0M |  | 
| ![[   ]](/icons/layout.gif) | ANX MDA June 30, 2021 FINAL.pdf | 22-Feb-2023 10:38 | 1.0M |  | 
| ![[   ]](/icons/layout.gif) | Q3 F17 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 530K |  | 
| ![[   ]](/icons/layout.gif) | Q1 F17 Interim Financial Statement.pdf | 22-Feb-2023 10:38 | 506K |  | 
| ![[   ]](/icons/layout.gif) | FY2015 Q2 MD&A.pdf | 22-Feb-2023 10:38 | 165K |  | 
| 
 | 
|---|